🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
TELO-SCOPE is a national, multi-centre, double-blind, placebo-controlled, r...
Status
Terminated
Location
John Hunter Hospital
Start Date
2021-09-07
Trial ID
NCT04638517
MOMENTUM is a randomized, double-blind, active control Phase 3 trial intend...
Status
Completed
Location
Mayo Clinic Hospital - Phoenix
Start Date
2020-02-07
Trial ID
NCT04173494
Treatments Being Tested
The drug being tested in this study is low doses of Optina (formerly known ...
Status
Completed
Location
Multiple Locations
Start Date
2011-01
Trial ID
NCT02002403
Treatments Being Tested
Single-arm, open-label, single center study to assess the efficacy and safe...
Status
Unknown
Location
Peking University Insititute of Hematology, Peking University People's Hospital
Start Date
2020-07-08
Trial ID
NCT04481282
Treatments Being Tested
The aim of this study is to evaluate the efficacy between dienogest and dan...
Status
Unknown
Location
Department of Obstetrics and Gynecology, Far Eastern Memorial Hospital
Start Date
2023-02-25
Trial ID
NCT05697471
The purpose of this study is to determine the safety of topical FP1198 for ...
Status
Completed
Location
Women's Health Care
Start Date
2010-06
Trial ID
NCT01105793
Treatments Being Tested
Background: Endometriosis is a chronic gynecological condition defined by ...
Status
Completed
Location
Sharif Medical and Dental College
Start Date
2019-04-10
Trial ID
NCT07183787
This project explores the implication of the telomere pathway in ovarian pr...
Status
Completed
Location
Ivirma Madrid
Start Date
2020-01-30
Trial ID
NCT04058678
Treatments Being Tested
The purpose of this study is to determine the safety of three doses of topi...
Status
Completed
Location
Women's Health Research
Start Date
2007-01
Trial ID
NCT00744276
This phase II pilot trial studies how well ruxolitinib phosphate and danazo...
Status
Completed
Location
Mayo Clinic in Arizona
Start Date
2013-04
Trial ID
NCT01732445
Treatments Being Tested